Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System — Stella

Home/Paroxysmal Atrial Fibrillation/

View on ClinicalTrials.gov

Recruiting

Back to Paroxysmal Atrial Fibrillation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Croatia

Klinicki Bolnicki Centar Split, Split

Czechia

Na Homolce Hospital, Prague

Key details

Sponsor

Boston Scientific Corporation

Enrollment target

~200 participants

Started

February 2026

Primary completion

February 2028

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.